NASHVILLE, Tenn. – Caremark Rx Inc. (NYSE: CMX) has rescheduled its shareholder vote on the proposed merger with CVS Corp. (NYSE: CVS) for Friday, March 16, the company announced Saturday.
That information was mailed to shareholders Saturday as well, the company said, along with the supplemental disclosures required by the Delaware Court of Chancery, which Friday decided not to block the CVS/Caremark merger.
Everyone needs science. Science needs everyone.
The Amgen Foundation is guided by the belief that all students should have the opportunity…
Learn More
“We are pleased with the Court’s ruling,” Tom Ryan, chairman, president and CEO of CVS, said in a statement today. “Having already received antitrust clearance, we are poised to close our merger mid- March, immediately following the vote of CVS and Caremark shareholders.”
CVS, which on Friday had set its own shareholder meeting for March 9, today said that meeting will be delayed until later in March. It will inform shareholders of the new date “as promptly as possible.”
Additional information, including the text of Caremark’s supplemental disclosures, is available at www.cvscaremarkmerger.com.
